Hearing What’s Next: Guiding a Strategic Shift for a MedTech Innovator
A growing hearing-health company needed help shifting from DTC sales to an insurance-reimbursed model. The consultant sharpened payer strategy, refined the go-to-market plan, and aligned leadership around the transition—laying the groundwork for stronger insurer partnerships and broader patient access.
Client Overview
The Challenge / Mandate
Search Strategy
The Placement
The Outcome
Our client is a San Jose, California-based medical device company focused on improving hearing health and quality of life for individuals with hearing loss. They manufacture and sell hearing aids directly to consumers and through various channels. The company specializes in providing hearing aid solutions for mild to moderate hearing loss.
It’s their mission to change the way the world perceives hearing loss by making every aspect of the hearing journey as invisible as possible. From the design of their devices and intuitive mobile app to extensive personalization options, rechargeable batteries, and lifetime customer support, their goal is to amplify life without compromising lifestyle.
The client is shifting from a fully direct-to-consumer (DTC), over-the-counter commercial strategy to one that provides hearing devices as a reimbursable benefit through insurance carriers.
They required a seasoned healthcare consultant to refine and execute their payer strategy to grow the new business line. The role’s objectives included:
The client required a healthcare strategy consultant with a highly specific skill set to guide its transition from a direct-to-consumer sales model to a payer-driven reimbursement strategy. The search focused on individuals who could blend strategic vision with hands-on execution experience in healthcare and medical devices.
Key criteria included:
The search ultimately prioritized versatility, healthcare-specific strategic acumen, and a track record of successful execution in similarly fast-paced, evolving environments.
The selected consultant brought over a decade of cross-functional experience across investment banking, management consulting, corporate strategy, and corporate development within the healthcare and medical devices space. He had served in strategic roles at global medical device leaders, where he led corporate strategy development, M&A transactions, and post-merger integration initiatives.
His experience also included running a Project Management Office for a major medical device company and serving as a senior advisor to North America leadership teams. He had previously worked on value-based reimbursement strategies and pricing studies, aligning stakeholders around strategic priorities. Known for his ability to synthesize complex challenges and serve as a thought partner to executive teams, he was well-suited to lead the client’s shift toward payer engagement and insurance reimbursement.
The consultant successfully helped the client navigate the transition to a payer-driven model by:
His impact laid the groundwork for scalable growth under the new business model and positioned the client to build long-term insurer relationships that would expand patient access and market penetration.